13F HOLDINGS REPORT
BIOS Capital Management, LP
Quarter ended Q4 2024 · Filed February 10, 2025 · Accession 0001104659-25-010964
Total Value
$95.9M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,509,224 | $67.7M | 70.65% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,384,427 | $11.0M | 11.50% |
| 3 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $3.9M | 4.02% |
| 4 | LANTERN PHARMA INC | LTRN | 1,207,709 | $3.9M | 4.02% |
| 5 | AILERON THERAPEUTICS INC | RNTX | 1,498,751 | $3.4M | 3.60% |
| 6 | OPUS GENETICS INC | IRD | 2,480,983 | $3.0M | 3.08% |
| 7 | IN8BIO INC | INAB | 8,600,001 | $2.2M | 2.31% |
| 8 | AILERON THERAPEUTICS INC | RNTX | 192,000 | $441,600 | 0.46% |
| 9 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $350,717 | 0.37% |